ES455294A1 - Un procedimiento de preparacion de una fenilamidina sustituida. - Google Patents
Un procedimiento de preparacion de una fenilamidina sustituida.Info
- Publication number
- ES455294A1 ES455294A1 ES455294A ES455294A ES455294A1 ES 455294 A1 ES455294 A1 ES 455294A1 ES 455294 A ES455294 A ES 455294A ES 455294 A ES455294 A ES 455294A ES 455294 A1 ES455294 A1 ES 455294A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- alkoxy group
- amidines
- substituted phenyl
- oc2h5
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical class NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un procedimiento de preparación de una fenilamidina sustituida de fórmula general: **(Fórmula)** A representa el grupo -CH2-, -CHOH-, CH2O-, -CH2S-, -CH2NH-, OCH2-, -SCH2-, -NH-, NHOOCH2-, -CH2NHCH2-NHCH2-; X1 representa el átomo de hidrógeno, un átomo de halógeno (preferiblemente C1 y F), un grupo alquilo C1-C4 (preferiblemente CH3) o un grupo alcoxi C1-C4 (preferiblemente CH3) o un grupo alcoxi C1-C4 (preferiblemente OCH3 y OC2H5); X2 representa un átomo de halógeno (preferiblemente C1 y F), un grupo alquilo C1-C4 (preferiblemente CH3) o un grupo alcoxi C1-C4 (preferiblemente OCH3 y OC2H5); Z representa el grupo 2-pirimidinilo.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES466887A ES466887A2 (es) | 1977-01-24 | 1978-02-10 | Un procedimiento de preparacion de una fenilamidina substituida. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2895/76A GB1538097A (en) | 1976-01-26 | 1976-01-26 | Substituted phenyl-amidines |
Publications (1)
Publication Number | Publication Date |
---|---|
ES455294A1 true ES455294A1 (es) | 1978-01-01 |
Family
ID=9748048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES455294A Expired ES455294A1 (es) | 1976-01-26 | 1977-01-24 | Un procedimiento de preparacion de una fenilamidina sustituida. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4146647A (es) |
JP (1) | JPS5953895B2 (es) |
BE (1) | BE850723A (es) |
CA (1) | CA1074797A (es) |
CH (1) | CH620901A5 (es) |
DE (1) | DE2702119C2 (es) |
DK (1) | DK30277A (es) |
ES (1) | ES455294A1 (es) |
FR (1) | FR2338927A1 (es) |
GB (1) | GB1538097A (es) |
IE (1) | IE44416B1 (es) |
LU (1) | LU76641A1 (es) |
NL (1) | NL188573C (es) |
SE (1) | SE440501B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH630606A5 (en) * | 1977-02-15 | 1982-06-30 | Lafon Labor | Phenylamidine derivatives useful especially in therapeutics |
DE2961710D1 (en) * | 1978-10-09 | 1982-02-18 | Ciba Geigy Ag | 2-(alpha-phenoxy-alkyl)-imidazolines and their salts, their preparation and use, and agents against phytoparasitic and zooparasitic mites containing them |
DE2965415D1 (en) * | 1978-11-03 | 1983-06-16 | Bayer Ag | Anilinomethyloxime ethers and processes for their production |
US4260626A (en) * | 1979-03-26 | 1981-04-07 | Richardson-Merrell Inc. | Tetrahydro and imidazoline antisecretory compounds |
US4616085A (en) * | 1980-06-19 | 1986-10-07 | Petrolite Corporation | Thioethers of imidazolines |
FR2506764A1 (fr) * | 1981-05-26 | 1982-12-03 | Synthelabo | Derives d'amidoximes, leur preparation et leur application en therapeutique |
US5227484A (en) * | 1982-01-14 | 1993-07-13 | Merck Patent Gmbh | Anisotropic compounds having nematic phase and liquid crystal mixtures |
FR2549049B1 (fr) * | 1983-07-13 | 1986-06-20 | Chauvin Blache Lab | Nouvelles amidines, leur procede de preparation et leur application therapeutique |
US4659363A (en) * | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
GB9509930D0 (en) * | 1995-05-17 | 1995-07-12 | Smithkline Beecham Corp | Method for preparing certain acetonitriles |
BRPI0707315A2 (pt) * | 2006-01-27 | 2011-05-03 | Hoffmann La Roche | uso de 2-imidazol substituìdo de derivados de imidazolina |
WO2008046756A1 (en) * | 2006-10-19 | 2008-04-24 | F. Hoffmann-La Roche Ag | Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
ATE546437T1 (de) * | 2006-10-19 | 2012-03-15 | Hoffmann La Roche | Aminomethyl-4-imidazole |
BRPI0718054A2 (pt) * | 2006-11-02 | 2013-11-05 | Hoffmann La Roche | 2-imidazóis substituídos como moduladores de receptores associados à traços de aminas |
KR101134226B1 (ko) * | 2006-11-16 | 2012-04-10 | 에프. 호프만-라 로슈 아게 | 치환된 4-이미다졸 |
BRPI0720047A2 (pt) * | 2006-12-13 | 2013-12-24 | Hoffmann La Roche | 2-imidazóis como ligantes para receptores associados a aminas de traço (taar) |
US20080146523A1 (en) * | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
JP5248528B2 (ja) * | 2007-02-02 | 2013-07-31 | エフ.ホフマン−ラ ロシュ アーゲー | Cns疾患用のtaar1リガンドとしての新規2−アミノオキサゾリン |
RU2460725C2 (ru) * | 2007-02-15 | 2012-09-10 | Ф. Хоффманн-Ля Рош Аг | Новые 2-аминооксазолины в качестве лигандов taar1 |
CN101687812A (zh) | 2007-07-02 | 2010-03-31 | 弗·哈夫曼-拉罗切有限公司 | 对痕量胺相关受体(taar)具有良好亲和性的2-咪唑啉化合物 |
MX2009013745A (es) * | 2007-07-03 | 2010-01-26 | Hoffmann La Roche | 4-imidazolinas y su uso como antidepresivos. |
EP2183216A1 (en) * | 2007-07-27 | 2010-05-12 | F. Hoffmann-Roche AG | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
AU2008281877A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of CNS disorders |
WO2009019149A1 (en) * | 2007-08-03 | 2009-02-12 | F. Hoffmann-La Roche Ag | Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
BRPI0916363A2 (pt) * | 2008-07-24 | 2018-05-29 | Hoffmann La Roche | derivados de 4,5-di-hidro-oxazol-2-ila |
US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
JPWO2013137371A1 (ja) * | 2012-03-15 | 2015-08-03 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
BR112018015389B1 (pt) | 2016-03-17 | 2023-12-19 | F. Hoffmann-La Roche Ag | Derivado de 5-etil-4-metil-pirazol-3-carboxamida, seu processo de fabricação, preparação farmacêutica oral e uso |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE598730A (es) * | 1960-01-01 | |||
US3115525A (en) * | 1960-04-21 | 1963-12-24 | Wassermann S P A Soc It Per Sp | Halogen-substituted amidoximes |
US3394181A (en) * | 1964-06-29 | 1968-07-23 | Sterling Drug Inc | Phenoxy-lower-alkyl-amidoximes and phenylamino-lower-alkyl-amidoximes |
US3445517A (en) * | 1966-06-03 | 1969-05-20 | Lilly Co Eli | Aryl acetamidines |
FR2036958A6 (es) * | 1969-04-23 | 1970-12-31 | Orsymonde | |
FR2149264B1 (es) * | 1971-08-13 | 1974-09-06 | Orsymonde | |
US3775478A (en) * | 1972-05-30 | 1973-11-27 | Dow Chemical Co | Substituted phenylthioamidines |
FR2207706B1 (es) * | 1972-11-24 | 1975-11-28 | Orsymonde | |
US3939912A (en) * | 1975-03-21 | 1976-02-24 | Continental Oil Company | Method for reducing the production of water from oil wells |
-
1976
- 1976-01-26 GB GB2895/76A patent/GB1538097A/en not_active Expired
-
1977
- 1977-01-11 CH CH27377A patent/CH620901A5/fr not_active IP Right Cessation
- 1977-01-20 DE DE2702119A patent/DE2702119C2/de not_active Expired
- 1977-01-20 IE IE110/77A patent/IE44416B1/en not_active IP Right Cessation
- 1977-01-20 FR FR7701595A patent/FR2338927A1/fr active Granted
- 1977-01-24 ES ES455294A patent/ES455294A1/es not_active Expired
- 1977-01-24 CA CA270,277A patent/CA1074797A/en not_active Expired
- 1977-01-25 US US05/762,774 patent/US4146647A/en not_active Expired - Lifetime
- 1977-01-25 BE BE174356A patent/BE850723A/xx not_active IP Right Cessation
- 1977-01-25 LU LU76641A patent/LU76641A1/xx unknown
- 1977-01-25 SE SE7700777A patent/SE440501B/xx not_active IP Right Cessation
- 1977-01-25 DK DK30277A patent/DK30277A/da not_active Application Discontinuation
- 1977-01-26 NL NLAANVRAGE7700806,A patent/NL188573C/xx not_active IP Right Cessation
- 1977-01-26 JP JP52007602A patent/JPS5953895B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2338927B1 (es) | 1980-10-10 |
CH620901A5 (es) | 1980-12-31 |
SE7700777L (sv) | 1977-07-27 |
BE850723A (fr) | 1977-05-16 |
JPS5953895B2 (ja) | 1984-12-27 |
LU76641A1 (es) | 1977-06-24 |
GB1538097A (en) | 1979-01-10 |
IE44416L (en) | 1977-07-26 |
SE440501B (sv) | 1985-08-05 |
JPS52105131A (en) | 1977-09-03 |
US4146647A (en) | 1979-03-27 |
NL188573C (nl) | 1992-08-03 |
DK30277A (da) | 1977-07-27 |
CA1074797A (en) | 1980-04-01 |
DE2702119C2 (de) | 1986-07-10 |
FR2338927A1 (fr) | 1977-08-19 |
IE44416B1 (en) | 1981-11-18 |
DE2702119A1 (de) | 1977-07-28 |
NL7700806A (nl) | 1977-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES455294A1 (es) | Un procedimiento de preparacion de una fenilamidina sustituida. | |
ES8400737A1 (es) | "un procedimiento para preparar derivados de nicotinamida". | |
ES462422A1 (es) | Procedimiento para la preparacion de compuestos derivados den-alquil-sulfo-noxi-acetil-anilinas. | |
ES8101550A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-pirrolidin-metanol. | |
GB1528440A (en) | Process for the preparation of cyclic ketones | |
ES454824A1 (es) | Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina. | |
ES464045A1 (es) | Un procedimiento para la produccion de una gamma-pirona. | |
JPS52118483A (en) | Nicotinylaminotriazine derivatives | |
ES395766A1 (es) | Procedimiento para la obtencion de derivados de la hidan- toina. | |
ES420638A1 (es) | Procedimiento para la preparacion de derivados de quinoli- na. | |
ES421182A1 (es) | Procedimiento para preparar 1-fenoxi-3-fenoxi-etilamino-2- propanoles. | |
ES450498A1 (es) | Procedimiento para la preparacion de derivados de la 6-pi- peracinil-11-metilen-morfantridina. | |
ES394322A1 (es) | Procedimiento para la preparacion de 2-bencifenoles susti- tuidos. | |
JPS5293771A (en) | Benzotriazoles | |
ES465044A1 (es) | Procedimiento para la obtencion de derivados de la adamanti-lamina | |
IT7924113A0 (it) | Procedimento per produrre eteri bis (n,n-dialchilammino) alchilici. | |
ES465761A1 (es) | Procedimiento para la obtencion de compuestos de acido 3-ha-logenosulfonil-tiofen-carboxilico. | |
ES451741A2 (es) | Procedimiento para preparar derivados de naftiridina. | |
ES460297A1 (es) | Un compuesto. | |
ES455592A1 (es) | Procedimiento para la preparacion de hidrazinas. | |
ES466067A1 (es) | Procedimiento para la obtencion de 4-(fenil)-1-aza-cicloal- canos alifaticamente sustituidos | |
ES457895A1 (es) | Metodo para preparar derivados de tirosina. | |
ES459371A1 (es) | Metodo de obtencion de intermedios utilizables en la prepa- racion de prostaglandinas. | |
ES8203853A1 (es) | Un procedimiento para preparar nuevos derivados de naftimi- dazol y naftoxazol | |
ES393339A1 (es) | Un procedimiento para la preparacion de derivados de nafto-quinona. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19931113 |